Literature DB >> 11487022

Tissue factor--a receptor involved in the control of cellular properties, including angiogenesis.

J Chen1, A Bierhaus, S Schiekofer, M Andrassy, B Chen, D M Stern, P P Nawroth.   

Abstract

Tissue factor (TF), the major initiator of blood coagulation, serves as a regulator of angiogenesis, tumor growth and metastasis. In several models, TF expression mediates upregulation of the proangiogenic vasular endothelial growth factor (VEGF) that can directly act on endothelial cells to promote vessel formation. This occurs through ligand binding, activation of signaling cascades, signal transduction and alteration of growth factor expression and is mediated by both, coagulation-dependent and -independent pathways. Depending on the cell type and the biological settings, TF seems to affect cellular properties through (i) factor VIIa (FVIIa)-dependent proteolysis of factor Xa (FXa) and thrombin and subsequent activation of proteinase activated receptor (PAR) -1 and PAR-2, (ii) through direct FVIIa signaling and mitogen activated protein (MAP) kinase activation, that is conferred by a not yet identified receptor, (iii) through interaction of FVII(a) proteolytic activity and signaling of the cytoplasmic domain and (iv) through cytoplasmic signaling independent of ligand binding. The role of phosphorylation of the cytoplasmic domain and the pathways controlling phosphorylation of TF remain poorly understood.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487022

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  24 in total

1.  Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor.

Authors:  Maria Loreto Bravo; Mauricio P Pinto; Ibeth Gonzalez; Barbara Oliva; Sumie Kato; Mauricio A Cuello; Carol A Lange; Gareth I Owen
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 2.  Tumor vascular infarction: prospects and challenges.

Authors:  Rana Jahanban-Esfahlan; Khaled Seidi; Nosratollah Zarghami
Journal:  Int J Hematol       Date:  2017-01-02       Impact factor: 2.490

3.  2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells.

Authors:  Marisol Quezada; Jorge Diaz; Soledad Henriquez; Maria Loreto Bravo; Evelyn Aranda; Barbara Oliva; Manuel Villalon; Sumie Kato; Mauricio A Cuello; Jan J Brosens; Carol A Lange; Gareth I Owen
Journal:  Horm Cancer       Date:  2010-06       Impact factor: 3.869

4.  P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Daniel J Brat; Erwin G Van Meir
Journal:  Cancer Res       Date:  2014-01-07       Impact factor: 12.701

5.  Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis.

Authors:  Benqiang Rao; Yuanhong Gao; Jun Huang; Xiaoyan Gao; Xinhui Fu; Meijin Huang; Jiayin Yao; Jingping Wang; Wanglin Li; Junxiao Zhang; Huanliang Liu; Lei Wang; Jianping Wang
Journal:  Int J Colorectal Dis       Date:  2011-03-15       Impact factor: 2.571

Review 6.  Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.

Authors:  Sara C Sebag; Julie A Bastarache; Lorraine B Ware
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

7.  Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus.

Authors:  Eric W Holroyd; Sinny Delacroix; Katarina Larsen; Adriana Harbuzariu; Peter J Psaltis; Ling Wang; Shuchong Pan; Thomas A White; Tyra A Witt; Laurel S Kleppe; Cheryl S Mueske; Debabrata Mukhopadhyay; Robert D Simari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-05       Impact factor: 8.311

8.  Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis.

Authors:  Hao-Lan He; Ji-Bin Zhang; Qian Li
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.

Authors:  Malgorzata Kamocka; Morris Pollard; Mark Suckow; Wojciech P Mielicki; Elliot D Rosen
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

10.  The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer.

Authors:  Carolyn A Staton; Andrew S A Chetwood; Iain C Cameron; Simon S Cross; Nicola J Brown; Malcolm W R Reed
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.